Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis

Neurology: Neuroimmunology and NeuroInflammation

Volumn 2, Issue 2, 2015, Pages e75-

  Körtvelyessy, Peter ^a   Bauer, Jan ^b   Stoppel, Christian M ^c   Brück, Wolfgang ^d   Gerth, Ivonne ^a   Vielhaber, Stefan ^a   Wiedemann, Falk R ^e   Heinze, Hans J ^a   Bartels, Claudius ^a   Bien, Christian G ^f  

^a University Clinic Magdeburg   (Germany)

^b Medical University of Vienna   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e Median Clinic NRZ Magdeburg   (Germany)

^f EPILEPSY CENTER BETHEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPR2 ANTIBODY; CD20 ANTIGEN; COMPLEMENT; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; PREDNISOLONE; SYNDECAN 1; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; AMNESIA; AMYGDALA; ANTIBODY TITER; ARTICLE; AUDITORY HALLUCINATION; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BRAIN SIZE; CASE REPORT; CASPR2 ANTIBODY ASSOCIATED ENCEPHALITIS; CD3+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPLEMENT DEPOSITION; CORTICOSTEROID THERAPY; ENCEPHALITIS; HIPPOCAMPAL SCLEROSIS; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; MIDDLE AGED; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIVASCULAR SPACE; PLASMA CELL; PRIORITY JOURNAL; RIGHT HIPPOCAMPUS; SEIZURE; SHORT TERM MEMORY; TEMPORAL LOBE; TEMPORAL LOBE EPILEPSY; WHOLE BODY PET;

EID: 84955620155     PISSN: None     EISSN: 23327812     Source Type: Journal    
DOI: 10.1212/NXI.0000000000000075     Document Type: Article

References (7)

1. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303-311.
2. Irani SR, Pettingill P, Kleopa KA, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neu-romyotonia. Brain 2010;133:2734-2748.
3. Reiber H, Lange P. Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin Chem 1991;37:1153-1160.
4. Bien CG, Vincent A, Barnett MH, et al. Immunopathology of autoantibody-associated encephalitides: clues for patho-genesis. Brain 2012;135:1622-1638.
5. Martinez-Hernandez E, Horvath J, Shiloh-Malawsky Y, et al. Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis. Neurology 2011;77:589-593.
6. Tuzun E, Zhou L, Baehring JM, et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encepha litis associated with ovarian teratoma. Acta Neuropathol 2009;118:737-743.
7. Paterson RW, Zandi MS, Armstrong R, et al. Clinical rele vance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. J Neurol Neurosurg Psychiatry 2014;85:625-630.